ABC | Volume 111, Nº4, Octuber 2018

Original Article Borges et al Inadequate management of antiplatelet agents Arq Bras Cardiol. 2018; 111(4):596-604 16. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, EckmanMH, et al. Perioperativemanagement of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-e50S. 17. Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. Sociedade Brasileira de Cardiologia. [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis]. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20. 18. Malaquias MV, Souza WK, Plavnik FL, Rodrigues CI, Brandão AA, Neves MF, et al; Sociedade Brasileira de Cardiologia. 7ª diretriz brasileira de hipertensão arterial. Arq Bras Cardiol. 2016;107(3Supl.3):1-83. 19. World Health Organization. (WHO). Obesity: preventing and managing the globalepidemic.ReportofaWHOConsultation.(TechnicalReportSeries894). 20. GualandroDM, Yu PC, Caramelli B, Marques AC, CalderaroD, Fornari LS, et al. 3rdGuideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2017;109(3 Suppl 1):1-104. 21. Joseph B, Rawashdeh B, Aziz H, Kulvatunyou N, Pandit V, Jehangir Q, et al. An acute care surgery dilemma: emergent laparoscopic cholecystectomy in patients on aspirin therapy. Am J Surg. 2015;209(4):689-94. 22. Devereaux PJ, MrkobradaM, Sessler DI, Leslie K, Alonso-Coello P, Kurz A,et al; POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370(16):1494-503. 23. Wolf AM, Pucci MJ, Gabale SD, McIntyre CA, Irizarry AM, Kennedy EP, et al. Safety of perioperative aspirin therapy in pancreatic operations. Surgery. 2014:155(1):39-46. 24. OscarssonA, Gupta A, FredriksonM, Jrhult J, NystrmM, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305-12. 25. Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM. Clopidogrel and bleeding after general surgery procedures. Am Surg. 2008;74(8):721-5. 26. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):234S-64S. 27. Burger W, Chemnitius JM, Kneissl GD, Rocker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperativewithdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005;257(5):399-414. 28. Collyer TC, Reynolds HC, Truyens E, Kilshaw L, Corcoran T. Perioperative management of clopidogrel therapy: the effects on in-hospital cardiac morbidity in older patients with hip fractures. Br J Anaesth. 2011;107(6):911-5. 29. Bollati M, Gaita F, Anselmino M. Antiplatelet combinations for prevention of atherothrombotic events. Vasc Health RiskManag. 2011;7 Jan 12:23-30. 30. Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al; CURRENT-OASIS 7 trial investigators. Double-dose versus standard- dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010;376(9748):1233-43. 31. Li L, Geraghty OC, Mehta Z, Rothwell PM, Study OV. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390(10093):490-9. 32. Olivetti G. Melissari M, Capasso JM, Anversa P. Cardiomyopaty of the aging human heart: myocyte loss and reactive cellular hypertrophy. Cir Res.1991;68(6):1560-8. 33. Fernandes EO, Guerra EE, Pitrez FA, Fernandes FM, Rosito GB, Gonzáles HE, et al. Avaliação pré-operatória e cuidados em cirurgia eletiva: recomendações baseadas em evidências. Revista da AMRIGS, Porto Alegre. 2010;54(2):240-58. 34. Stracieri LD. Cuidados e complicações pós-operatórias. Medicina (Ribeirão Preto). 2008;41(4):465-8. 35. Qureshi AI, Suri MF, Saad M, Hopkins LN. Educational attainment and risk of stroke andmyocardial infarction. Med Sci Monit. 2003;9(11):CR466-73. 36. Samal D, Greisenegger S, Auff E, Lang W, Lalouschek W. The relation between knowledge about hypertension and education in hospitalized patients with stroke in Vienna. Stroke. 2007;38(4):1304-8. 37. Skowron KB, Angelos P. Surgical informed consent revisited: time to revise the routine? World J Surg. 2017;41(1):1-4. 38. GersteinNS, Schulman PM, GersteinWH, Petersen TR, Tawil I. Shouldmore patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012;255(5):811-9. 603